July 14, 2015 / 11:59 AM / 2 years ago

J&J profit rises 4 pct on pharma sales

July 14 (Reuters) - Johnson & Johnson reported a 4 percent rise in quarterly profit as sales of its mainstay older drugs managed to offset the impact of a strong dollar on overseas revenue.

The company's net profit rose to $4.52 billion, or $1.61 per share, in the second quarter, from $4.33 billion, or $1.51 per share, a year earlier.

Excluding special items, the company earned $1.71 per share.

Revenue fell nearly 9 percent to $17.79 billion.

Sales of its medical devices fell 12.2 percent to $6.36 billion.

Reporting by Vidya L Nathan in Bengaluru; Editing by Sriraj Kalluvila

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below